Skip to content
healthcare.dev
Get a free key

Fexofenadine Hydrochloride

NDC 45802-847, fexofenadine hydrochloride, tablet, film coated, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-847
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA212971
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEXOFENADINE HYDROCHLORIDE180 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
45802-847-78458020847781 BOTTLE in 1 CARTON (45802-847-78) / 100 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 45802-847 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.